Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 September, 2018 00:13 IST
Glenmark to introduce generic Seretide Accuhaler in Denmark
Source: IRIS | 16 May, 2018, 11.59AM
Comments  |  Post Comment

Glenmark Pharmaceuticals Europe (Glenmark) today announced that it has launched a generic version of Seretide Accuhaler in Denmark. This is Glenmark's first inhaled respiratory product launch in Europe.
 
Glenmark is the first generic company to receive regulatory approval for substitution in Denmark for its generic of Seretide Accuhaler Glenmark had entered into a strategic development & licensing agreement with Celon Pharma S.A. (Celon) to develop and market a generic version of GlaxoSmithKline's Seretide Accuhaler product-Fluticasone/Salmeterol dry powder inhaler in 15 European countries. Fluticasone/Salmeterol dry powder inhaler is a combination product for the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Glenmark has already received National Marketing Authorizations for the product in Sweden, Finland, Norway and Iceland.

''Denmark is the first country in Europe where Glenmark has launched its generic Fluticasone/Salmeterol Dry powder Inhaler (DPI) and we plan to commercialize this product across the Nordics in the near future. The grant of substitution in Denmark for this complex product affirms Glenmark's capabilities in the respiratory segment,'' said Achin Gupta, Executive Vice President & Business Head of Europe and Latin America, Glenmark Pharmaceuticals.

(Q,N,C,F)*

Shares of the company gained Rs 8.25, or 1.63%, to trade at Rs 514.50. The total volume of shares traded was 11,625 at the BSE (11.46 a.m., Wednesday).



Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Strides Pharma Science gets ACCC approval for merger of Arrow and Apotex Australia - 20-Sep-2018 10:15
Bajaj Finserv ties up with Wochit - 20-Sep-2018 10:09
Sensex ends 170 points lower; Nifty settles at 11,234 - 19-Sep-2018 16:07
Glenmark Pharma inducted into DJSI Emerging Market 2018 - 19-Sep-2018 12:09
Rites secures additional contract worth Rs 4.36 bn from Indian Railways - 19-Sep-2018 12:00
TVS Motor Co strengthens presence in Mexico - 19-Sep-2018 11:56
Himachal Futuristic Communications bags order worth Rs 6.11 bn - 19-Sep-2018 11:52
Tata Steel completes acquisition of Creative Port Development - 19-Sep-2018 11:48
SABIC acquires 24.99% stake in Clariant globally - 19-Sep-2018 11:45
Tata Power launches its VoiceBOT TINA - 19-Sep-2018 11:42
Sensex gains 77 points; Nifty above 11,300-level - 19-Sep-2018 10:32
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer